NASDAQ : BIOT
$0.0 (0.1%)
NASDAQ
Tomoki Nagano
Biotechnology
Healthcare
BIOT
2
US
USD
0.00
0.95
0.95
0.29
0.00
-$
0.00
-425275.37
-1.18
-0.05
-$
0.00%
0.00%
-121755.40%
-5279160.73%
-0.96
0.00
0.00
0/5
0 Analysts
%
No financial score data available.
No key metrics data available.
| Name | Title |
|---|---|
| Kenta Nakajima | Head of Manufacturing (Japan & International) and Executive Officer |
| Fumihiro Nagano | Chief Marketing Officer & Representative Director |
| Futa Sakakibara | Chief Technical Officer |
| Masashi Ohmatsu | Chief Financial Officer |
| Yuji Naito | Senior Executive Managing Director, Director & COO |
| Takashi Boda | Head of Sales, Head of Value Athlete Division & Executive Officer |
| Tomoki Nagano | Founder, Group Chairman & CEO |
No votes yet today — be the first to share your view!
About Instinct Bio Technical Co. Holdings Inc. (NASDAQ:BIOT) Stock
An integrated regenerative medicine and longevity company focused on the research, manufacturing, and commercialization of regenerative health technologies, stem cell-derived products, wellness solutions, and advanced skincare. ...
2026-08-10 07:00:00
NEW YORK and TOKYO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (Nasdaq: BIOT) ("Instinct Bio" or the "Company") today announced a cooperation agreement with PT PARVA CANDELA ("PARVA"), an Indonesian cosmetics manufacturer and distributor, to jointly develop Indonesia's cosmetics and personal care market under a "Made in Indonesia, Powered by Japanese Formulation Expertise" concept.
2026-07-29 10:28:19
NEW YORK and TOKYO, July 29, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (NASDAQ: BIOT) ("Instinct Bio" or the "Company") today announced its decision to bring its own Japanese aesthetic healthcare brand "GENRÊVER CLINIC" to Indonesia and, together with a local Indonesian physician, to launch a subscription-model membership beauty clinic business.
2026-07-29 10:28:00
BIOT to Launch Indonesia's First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” Building a Recurring-Revenue Platform
2026-07-28 10:01:00
Transformative funding agreement equips Instinct Bio with discretionary capital to scale its longevity-focused ecosystem and capture market opportunities. Transformative funding agreement equips Instinct Bio with discretionary capital to scale its longevity-focused ecosystem and capture market opportunities.
Frequently Asked Questions
What is the current Instinct Bio Technical Co. Holdings Inc. (BIOT) stock price?
Instinct Bio Technical Co. Holdings Inc.(NASDAQ:BIOT) stock price is $0.4019 in the last trading session. During the trading session, BIOT stock reached the peak price of $50 while $0.38 was the lowest point it dropped to. The percentage change in BIOT stock occurred in the recent session was 0.1% while the dollar amount for the price change in BIOT stock was $0.0.
BIOT's industry and sector of operation?
The NASDAQ listed BIOT is part of Biotechnology industry that operates in the broader Healthcare sector.
Who are the executives of BIOT?
Kenta Nakajima
| Head of Manufacturing (Japan & International) and Executive Officer
Fumihiro Nagano
| Chief Marketing Officer & Representative Director
Futa Sakakibara
| Chief Technical Officer
Masashi Ohmatsu
| Chief Financial Officer
Yuji Naito
| Senior Executive Managing Director, Director & COO
How many employees does BIOT have?
Number of BIOT employees currently stands at 2. BIOT operates from 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, US.
Link for BIOT official website?
Official Website of BIOT is: https://instinct-biot.com
How do I contact BIOT?
BIOT could be contacted at phone #None and can also be accessed through its website. BIOT operates from 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, US.
How many shares of BIOT are traded daily?
The average number of BIOT shares traded daily for last 3 months was 1.59M.
What is the market cap of BIOT currently?
The market value of BIOT currently stands at $1.73M with its latest stock price at $0.4019